OpenAlex konusu

Lymphadenopathy Diagnosis and Analysis

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 735 eser 2 yazar konusu

Çalışmalar

735 eser

Kikuchi–Fujimoto Disease: analysis of 244 cases 2006
OpenAlex üst %10 OpenAlex 97.3%
Özet henüz yok.
Kikuchi Fujimoto Disease analysis of 244 cases 2007
YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 97.3%
Özet henüz yok.
- ŞÜKRÜ YILDIRIM
Kikuchi–Fujimoto Disease: analysis of 244 cases. 2007
YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 97.3%
Özet henüz yok.
- ŞÜKRÜ YILDIRIM
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%
BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-1…
- GÜLDANE CENGİZ SEVAL
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%
BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-1…
- OSMAN İLHAN
Rosai Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low dose thalidomide therapy 2021
YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %1 OpenAlex 99.7%
BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-1…
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- HAKAN YILMAZ
- ÜLKÜ CEREN KÖKSOY
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- SERDAR ÇULCU
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- CAN KONCA
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- MEHMET ALİ KOÇ
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- MEHMET ÇAĞLAR ÇAKICI
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
BACKGROUND: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on po…
- HÜSEYİN ÖZGÜR KAZAN

Akademisyenler

2 akademisyen